Propgene Inc. (Japan)

No content in this language yet.

Propgene Inc. (株式会社プロップジーン) is a Japanese company based in Suginami, Tokyo, operating in the genetic testing and clinical laboratory sector. The company's official website describes its core activity as genetic chip testing in areas related to various diseases, including dementia and autism — a field it characterizes as one it has assembled itself and that is not available elsewhere. This suggests the company has developed proprietary genetic testing panels or services in these disease areas. The company operates a clinical laboratory, the PropGene Health Laboratory (プロップジーン衛生検査所), located in Suginami Ward, a two-minute walk from Koenji Station. This laboratory has provided PCR and other testing services, particularly during the COVID-19 pandemic. During the pandemic, Propgene participated in the Tokyo Metropolitan Government's free PCR testing program (PCR等検査無料化事業), administered through the Tokyo Metropolitan Bureau of Social Welfare and Public Health. The company's announcements document the extension and eventual termination of free testing periods. The free testing program ended on May 6, 2023, following the program's conclusion on May 7, 2023. The company also participated in the vaccine-test package and universal testing promotion program, which ended on August 31, 2022, per government notification. In March 2024 (Reiwa 6), Propgene began selling SERO products. The company also introduces quality control control products on its website. Propgene maintains a privacy policy governing the protection of personal information and has published various announcements regarding its operations and services. The company is identified in Wikidata as a company in Suginami, Japan. It appears to be a privately held, relatively small Japanese enterprise focused on genetic testing and clinical laboratory services.

• Vaccine-test package and universal testing promotion program ended per government notification.

• Free PCR testing period ended, following the conclusion of the Tokyo Metropolitan Government's free PCR testing program on May 7, 2023.

• Propgene began selling SERO products.

A Japanese genetic testing and clinical laboratory company specializing in genetic chip testing for diseases such as dementia and autism, and providing PCR testing services.

• Genetic chip testing

  Genetic chip testing in areas related to various diseases including dementia and autism, described by the company as a field it has assembled itself and that is not available elsewhere.

• COVID-19 PCR testing

  PCR testing services provided through the PropGene Health Laboratory, including participation in the Tokyo Metropolitan Government's free PCR testing program.

• Quality control control products

  Quality control control products introduced on the company's official website.

• SERO products

  SERO products began being sold in March 2024 (Reiwa 6).

1. 1株式会社プロップジーン – PropGene Inc.pgi.jp
2. 2Propgene Inc. (Japan) - Wikidatawikidata.org